CORMEDIX INC. Payments for Repurchase of Warrants
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- CORMEDIX INC. payments for repurchase of warrants for the quarter ending 2014-12-31 was $0.00.
- CORMEDIX INC. payments for repurchase of warrants for the quarter ending 2014-09-30 was $0.00.
- CORMEDIX INC. payments for repurchase of warrants for the quarter ending 2014-06-30 was $0.00.
- CORMEDIX INC. payments for repurchase of warrants for the quarter ending 2014-03-31 was $0.00, a 100.00% decline year-over-year.
- CORMEDIX INC. payments for repurchase of warrants for fiscal 2014 was $0.00, a 100.00% decline from fiscal 2013.
- CORMEDIX INC. payments for repurchase of warrants for fiscal 2013 was $33.00K.
- CORMEDIX INC. payments for repurchase of warrants for fiscal 2012 was $0.00.
| Period end | Payments for Repurchase of Warrants 3 month | Payments for Repurchase of Warrants 12 month |
|---|---|---|
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $0.00 10-K · filed 2015-03-12 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | $0.00 derived: sum of 4 quarters · filed 2015-03-12 |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | $0.00 derived: sum of 4 quarters · filed 2015-03-12 |
| 2014-03-31 | $0.00 10-Q · filed 2014-05-15 | $0.00 derived: sum of 4 quarters · filed 2015-03-12 |
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $33.00K 10-K · filed 2015-03-12 |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | $33.00K derived: sum of 4 quarters · filed 2014-11-13 |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | $33.00K derived: sum of 4 quarters · filed 2014-08-14 |
| 2013-03-31 | $33.00K 10-Q · filed 2014-05-15 | $33.00K derived: sum of 4 quarters · filed 2014-05-15 |
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q/A 9 month · filed 2014-03-31 | $0.00 10-K · filed 2014-03-31 |
| 2012-09-30 | $0.00 derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2014-03-04 | |
| 2012-06-30 | $0.00 derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2014-03-04 | |
| 2012-03-31 | $0.00 10-Q/A · filed 2014-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |